| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Kauffman Michael78 | Director | Sell | 18,167 | $12.12 | $220,245.81 | -1.1% | -55.0% | -70.4% | |
| Feb 7, 2022 | Kauffman Michael78 | Director | Sell | 13,471 | $9.86 | $132,851.00 | -0.8% | -50.7% | -65.6% | |
| Feb 7, 2022 | Shah Jatin54 | EVP, Chief Medical Officer | Sell | 1,704 | $9.86 | $16,804.85 | -1.3% | -50.7% | -65.6% | |
| Feb 7, 2022 | Frenkel Ran78 | EVP, Chief Dev. Officer | Sell | 1,991 | $9.86 | $19,635.24 | -1.9% | -50.7% | -65.6% | |
| Feb 7, 2022 | Mason Michael88 | EVP, CFO &Treasurer | Sell | 3,947 | $9.86 | $38,925.31 | -6.9% | -50.7% | -65.6% | |
| Feb 7, 2022 | Shacham Sharon79 | Chief Scientific Officer | Sell | 13,471 | $9.86 | $132,851.00 | -0.8% | -50.7% | -65.6% | |
| Dec 2, 2021 | Mitchener Stephen72 | SVP, Chief Business Officer | Sell | 499 | $6.69 | $3,338.31 | -13.1% | -14.0% | -29.3% | |
| Jun 2, 2021 | Mitchener Stephen72 | SVP, Chief Business Officer | Sell | 528 | $9.29 | $4,905.12 | -17.6% | -37.4% | -34.1% | |
| May 7, 2021 | Shah Jatin54 | EVP, Chief Medical Officer | Buy | 23,250 | $8.60 | $199,991.85 | +21.4% | -29.4% | -27.6% | |
| May 6, 2021 | Bohlin Garen G | Director | Buy | 4,000 | $7.82 | $31,280.00 | New | -3.9% | -25.3% |